Innate Pharma IPHA
NASDAQ IPHA
$1.59 +0.05 (+3.25%)
As of: Nov 11, 2026 · 3:56 PM EST

Innate Pharma (IPHA) Buildings (2021)

Updated

Innate Pharma (IPHA) reported Buildings of $22,879 for the quarter ended Dec 31, 2021.

Analysis

Innate Pharma (IPHA) Buildings (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Innate Pharma 142.45 Mn -64.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 22,650.06
API Access

Innate Pharma Buildings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=buildings&ticker=IPHA&period=max&api_key=YOUR_API_KEY